Campbell & Co Investment Adviser’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Campbell & Co Investment Adviser's ANGO Position: Q4 2022 in Review
Campbell & Co Investment Adviser sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 19,879 shares — an estimated $407K sold.
Campbell & Co Investment Adviser first reported a position in ANGO in Q2 2017 and held it in 17 quarters. The position peaked at $784K in Q1 2019. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.
- Campbell & Co Investment Adviser reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 19,879 AngioDynamics shares in Q4 2022, an estimated $407K.
- Campbell & Co Investment Adviser first reported a position in AngioDynamics in Q2 2017 and held it in 17 quarters.
- Campbell & Co Investment Adviser's AngioDynamics position peaked at $784K in Q1 2019.
- 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.
Based on Campbell & Co Investment Adviser's 13F filing for Q4 2022, filed 14 Feb 2023.